In our study, the results of in vitro and in vivo experiments elucidate on SERT-targeted therapy of colon cancer, showing a novel feedback mechanism by which cancer cells maintain the homeostasis of intracellular serotonin, and suggesting a novel SSRIs-based strategy for colon cancer treatment. The gene discussed is SLC6A4; the disease is cancer.